Skip to main content
Top
Published in: Clinical and Experimental Nephrology 4/2009

01-08-2009 | Original Article

Evaluation of renal function and proteinuria based on mass health examinations in young Japanese obese adults

Authors: Kei Matsushita, Gen Yasuda, Masataka Shouda, Satoshi Umemura

Published in: Clinical and Experimental Nephrology | Issue 4/2009

Login to get access

Abstract

Background

Although obesity is recognized to be a risk factor for chronic kidney disease (CKD), few studies have reported the association between obesity and CKD in the young population. We investigated the relationship between obesity and renal function including proteinuria in young Japanese.

Methods

This cross-sectional study consisted of 16,031 men and 5,746 women aged from 20 to 39 years who received health examinations. The subjects were stratified into four age groups (20–24, 25–29, 30–34, and 35–39 years) or into four groups based on the number of risk factors (hypertension, hyperglycemia, dyslipidemia, and hyperuricemia). The relationship between obesity and risk factors and the relationship between obesity and estimated glomerular filtration rate (eGFR) were analyzed.

Results

There were no significant differences in eGFR between obese and nonobese groups, except in the male 35–39 years age group. Body mass index (BMI) in both men and women increased with increase in number of risk factors (P < 0.001). Multivariate analysis revealed that hypertension, hyperglycemia, dyslipidemia, and hyperuricemia were independently associated with obesity. Obesity and the risk factors were independently associated with proteinuria.

Conclusion

The present study indicated that obesity was an independent risk factor for proteinuria in healthy subjects younger than 40 years of age. The other risk factors were independently associated with obesity. These findings suggest that obesity causes proteinuria concomitantly with other risk factors such as hypertension, diabetes, and dyslipidemia in young adults.
Literature
1.
go back to reference National Health and Nutrition Survey: the Ministry of Health, Labor and Welfare of Japan, 2005. National Health and Nutrition Survey: the Ministry of Health, Labor and Welfare of Japan, 2005.
2.
go back to reference Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–69.CrossRefPubMed Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–69.CrossRefPubMed
3.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRefPubMed
4.
go back to reference Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167–74.CrossRefPubMed Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167–74.CrossRefPubMed
5.
go back to reference Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–40.CrossRefPubMed Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–40.CrossRefPubMed
6.
go back to reference Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369–74.CrossRefPubMed Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369–74.CrossRefPubMed
7.
go back to reference Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis. 2006;48:383–91.CrossRefPubMed Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis. 2006;48:383–91.CrossRefPubMed
8.
go back to reference Azegami M, Hongo M, Yanagisawa S, Yamazaki A, Sakaguchi K, Yazaki Y, et al. Characteristics of metabolic and lifestyle risk factors in young Japanese patients with coronary heart disease: a comparison with older patients. Int Heart J. 2006;47:343–50.CrossRefPubMed Azegami M, Hongo M, Yanagisawa S, Yamazaki A, Sakaguchi K, Yazaki Y, et al. Characteristics of metabolic and lifestyle risk factors in young Japanese patients with coronary heart disease: a comparison with older patients. Int Heart J. 2006;47:343–50.CrossRefPubMed
9.
go back to reference Azegami M, Hongo M, Yazaki Y, Yanagisawa S, Yamazaki A, Imamura H. Seasonal difference in onset of coronary heart disease in young Japanese patients: a comparison with older patients. Circ J. 2005;69:1176–9.CrossRefPubMed Azegami M, Hongo M, Yazaki Y, Yanagisawa S, Yamazaki A, Imamura H. Seasonal difference in onset of coronary heart disease in young Japanese patients: a comparison with older patients. Circ J. 2005;69:1176–9.CrossRefPubMed
10.
go back to reference Horio M, Imai E, Yasuda N, Hishida A, Matsuo S. Estimation of glomerular filtration rate for Japanese. J Jpn Soc Nephrol. 2008;50:221. (in Japanese abstract). Horio M, Imai E, Yasuda N, Hishida A, Matsuo S. Estimation of glomerular filtration rate for Japanese. J Jpn Soc Nephrol. 2008;50:221. (in Japanese abstract).
11.
go back to reference Examination committee of criteria for diagnosis of metabolic syndrome in Japan. Definition and criteria for diagnosis of metabolic syndrome. J Jpn Soc Intern Med. 2005;94:794–809. (in Japanese with English abstract).CrossRef Examination committee of criteria for diagnosis of metabolic syndrome in Japan. Definition and criteria for diagnosis of metabolic syndrome. J Jpn Soc Intern Med. 2005;94:794–809. (in Japanese with English abstract).CrossRef
12.
go back to reference Hakoda M, Masunari N, Yamada M, Fujiwara S, Suzuki G, Kodama K, et al. Serum uric acid concentration as a risk factor for cardiovascular mortality. J Rheumatol. 2005;32:906–12.PubMed Hakoda M, Masunari N, Yamada M, Fujiwara S, Suzuki G, Kodama K, et al. Serum uric acid concentration as a risk factor for cardiovascular mortality. J Rheumatol. 2005;32:906–12.PubMed
13.
go back to reference Examination committee of criteria for ‘obesity disease’ in Japan. Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987–92.CrossRef Examination committee of criteria for ‘obesity disease’ in Japan. Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987–92.CrossRef
15.
go back to reference Rho YH, Choi SJ, Lee YH, Ji JD, Choi KM, Baik SH, et al. The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci. 2005;20:1029–33.CrossRefPubMedPubMedCentral Rho YH, Choi SJ, Lee YH, Ji JD, Choi KM, Baik SH, et al. The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci. 2005;20:1029–33.CrossRefPubMedPubMedCentral
16.
go back to reference Cigolini M, Targher G, Tonoli M, Manara F, Muggeo M, De Sandre G. Hyperuricemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes Relat Metab Disord. 1995;19:92–6.PubMed Cigolini M, Targher G, Tonoli M, Manara F, Muggeo M, De Sandre G. Hyperuricemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes Relat Metab Disord. 1995;19:92–6.PubMed
17.
go back to reference Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, et al. Obesity-related glomerulopathy: insight from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology. 2006;147:44–50.CrossRefPubMed Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, et al. Obesity-related glomerulopathy: insight from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology. 2006;147:44–50.CrossRefPubMed
18.
go back to reference Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–509.CrossRefPubMed Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–509.CrossRefPubMed
19.
go back to reference Chen HM, Li SJ, Chen HP, Wang QW, Li LS, Liu ZH. Obesity-related glomerulopathy in China: a case series of 90 patients. Am J Kidney Dis. 2008;52:58–65.CrossRefPubMed Chen HM, Li SJ, Chen HP, Wang QW, Li LS, Liu ZH. Obesity-related glomerulopathy in China: a case series of 90 patients. Am J Kidney Dis. 2008;52:58–65.CrossRefPubMed
20.
go back to reference Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278:F817–22.CrossRefPubMed Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278:F817–22.CrossRefPubMed
21.
go back to reference Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens. 2008;26:831–43.CrossRefPubMed Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens. 2008;26:831–43.CrossRefPubMed
22.
go back to reference Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis. 2008;52(1):39–48.CrossRefPubMedPubMedCentral Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis. 2008;52(1):39–48.CrossRefPubMedPubMedCentral
23.
go back to reference Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871–80.CrossRefPubMed Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871–80.CrossRefPubMed
24.
go back to reference Bello AK, de Zeeuw D, El Nahas M, Brantsma AH, Bakker SJ, de Jong PE, et al. Impact of weight changes on albuminuria in the general population. Nephrol Dial Tranplant. 2007;20:1619–27.CrossRef Bello AK, de Zeeuw D, El Nahas M, Brantsma AH, Bakker SJ, de Jong PE, et al. Impact of weight changes on albuminuria in the general population. Nephrol Dial Tranplant. 2007;20:1619–27.CrossRef
25.
go back to reference Watanabe N, Hashimoto Y, Futamura A, Mashige F, Nakarai H, Nakahara K. Relationship between the prevalence of proteinuria and obesity in Japanese men. Rinsho Byori. 1999;47:271–4.PubMed Watanabe N, Hashimoto Y, Futamura A, Mashige F, Nakarai H, Nakahara K. Relationship between the prevalence of proteinuria and obesity in Japanese men. Rinsho Byori. 1999;47:271–4.PubMed
26.
go back to reference Tozawa M, Iseki K, Iseki C, Oshiro S, Ikeyama Y, Takishita S. Influence of smoking and obesity on the development of proteinuria. Kidney Int. 2002;62:956–62.CrossRefPubMed Tozawa M, Iseki K, Iseki C, Oshiro S, Ikeyama Y, Takishita S. Influence of smoking and obesity on the development of proteinuria. Kidney Int. 2002;62:956–62.CrossRefPubMed
27.
28.
go back to reference de Jong PE, Brenner BM. From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int. 2004;66:2109–18.CrossRefPubMed de Jong PE, Brenner BM. From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int. 2004;66:2109–18.CrossRefPubMed
Metadata
Title
Evaluation of renal function and proteinuria based on mass health examinations in young Japanese obese adults
Authors
Kei Matsushita
Gen Yasuda
Masataka Shouda
Satoshi Umemura
Publication date
01-08-2009
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 4/2009
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-009-0164-8

Other articles of this Issue 4/2009

Clinical and Experimental Nephrology 4/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.